home / stock / bfra / bfra news

BFRA News and Press, Biofrontera AG From 03/27/19

Stock Information
Company Name: Biofrontera AG
Stock Symbol: BFRA
Market: NASDAQ
Menu
BFRA BFRA Quote BFRA Short BFRA News BFRA Articles BFRA Message Board
Get BFRA Alerts

News, Short Squeeze, Breakout and More Instantly...
BFRA - Changes in the composition of the Supervisory Board

Leverkusen, Germany, March 27, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces that the Cologne Local District Court ( Amtsgericht ) dismissed Mr. Hansjörg Plaggem...
BFRA - Biofrontera provides corporate update; conference call details for March 26, 2019

Leverkusen, Germany, March 25, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces a conference call to be held tomorrow to provide a detailed corporate update on its acqui...

BFRA - Biofrontera +2% on acquisition of Cutanea Life Sciences

Biofrontera ( BFRA +2.4% ) enters into an agreement with Maruho, to acquire Cutanea Life Sciences for an initial purchase price of $1; Maruho holds ~20% of Biofrontera. More news on: Biofrontera AG, Biofrontera AG, Merger & acquisition news, Healthcare stocks news, Re...

BFRA - Biofrontera, Inc., USA, acquires Cutanea Life Sciences, Inc., USA

Ad-hoc Release pursuant to Art. 17 MAR Leverkusen, Germany, March 25, 2019 (GLOBE NEWSWIRE) -- Biofrontera Inc., USA (“Biofrontera”), a wholly owned subsidiary of Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113), today entered into an agreement to acquire all...
BFRA - Biofrontera up 4% on positive Ameluz data

Ultra-thinly traded Biofrontera ( BFRA +4.1% ) is up an 8x surge in volume, albeit on turnover of only 12,700 shares, on the heels of preliminary data from a Phase 3 clinical trial evaluating conventional photodynamic therapy (PDT) with topical gel Ameluz (aminolevulinic acid hydrochlo...

BFRA - Biofrontera Reports Positive Phase III Results with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neck

Ad-hoc Release pursuant to Art. 17 MAR Leverkusen, Germany, March 20, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today received positive preliminary results for the primary endpoint of its Phase III cl...

BFRA - Biofrontera AG and Maruho Co., Ltd. conclude cooperation agreement regarding branded generics and plan collaboration on expansion of indications and distribution of Ameluz®

Ad-hoc Release pursuant to Art. 17 MAR Leverkusen, Germany, March 19, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113), today signed an agreement to continue the expired research cooperation with Maruho Co., Ltd., Osaka, Japan (“Maruho”...
BFRA - Biofrontera: Why This Small German Company Can Become The Next Hot Stock

Biofrontera ( BFRA ; BFFTF ) has been gradually shifting from a biotech company into a focused pharmaceutical company with specialization in dermatology. The central turning point was the European approval of the self-developed medication Ameluz for the photodynamic therapy of actinic keratos...

BFRA - Biofrontera Honored with Prestigious Silver Stevie(R) Award for Outstanding U.S. Customer Service Department of the Year

Leverkusen, Germany, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the "Company"), an international biopharmaceutical company, today announced that its wholly owned US-subsidiary Biofrontera Inc. earned a Silver Stevie Award for outstanding ...

BFRA - Biofrontera implements new Falsified Medicines Directive

Leverkusen, Germany, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, has implemented all necessary safety measures defined in the new Commission Delegated Regulation (EU...
Previous 10 Next 10